Minerva Neurosciences, Inc Share Price

Minerva Neurosciences, Inc Share Price

NASDAQ: NERV | Micro Cap
$2.32
+$0.11 (4.98%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Minerva Neurosciences, Inc Stock Performance

Open
$2.21
Prev. Close
$2.21
Circuit Range
N/A
Day Range
$1.97 - $2.31
Year Range
$1.97 - $8.77
Volume
35,514
Average Traded
$2.06

Minerva Neurosciences, Inc Share Price Today

As of 31 October 2026, Minerva Neurosciences, Inc's share price is $2.32. The stock opened at $2.21, compared to its previous close of $2.21. During today's trading session, Minerva Neurosciences, Inc's share price traded between $1.97 and $2.31, with an average price of $2.14. Over the past 52 weeks, the stock has recorded a high of $8.77 and a low of $1.97. In terms of performance, Minerva Neurosciences, Inc's share price has declined by 63.98% over the last six months and is down 44.96% on a year-on-year basis.

Minerva Neurosciences, Inc Share Price Chart

Line chart of the Minerva Neurosciences, Inc price trend over the selected period. The price rose overall, ranging from 1.97 to 2.31, ending at 2.31.
$1.97$2.31
L
Show Current Price
H

Minerva Neurosciences, Inc Stock Fundamentals & Key Indicators

Market Cap
$19.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-8.28
Revenue (TTM)
$0.00
Return On Equity (TTM)
185.26%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
707.66%

Minerva Neurosciences, Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.74-$283.67-$125.40$16.65
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-10252.92%55.79%113.28%

Minerva Neurosciences, Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$32.11-$30.01$1.44-$293.42
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A6.54%104.80%-20476.39%

About Minerva Neurosciences, Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Minerva Neurosciences, Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.28
$2.31
-30.94%
Sep 2026
$4.58
$3.35
-34.92%
Aug 2026
$4.04
$5.14
+29.47%
Jul 2026
$5.43
$3.97
-28.73%
Jun 2026
$4.92
$5.57
+12.98%
May 2026
$6.38
$4.93
-23.45%
Apr 2026
$6.16
$6.44
+6.36%
Mar 2026
$6.23
$6.05
-8.05%
Feb 2026
$4.20
$6.58
+57.91%
Jan 2026
$4.01
$4.17
+0.97%
Dec 2025
$4.17
$4.13
+7.55%
Nov 2025
$3.99
$3.84
-8.90%

NERV Share Price FAQs